DK379886D0 - Praeparat og fremgangsmaade til behandling af svulster med udpg - Google Patents
Praeparat og fremgangsmaade til behandling af svulster med udpgInfo
- Publication number
- DK379886D0 DK379886D0 DK379886A DK379886A DK379886D0 DK 379886 D0 DK379886 D0 DK 379886D0 DK 379886 A DK379886 A DK 379886A DK 379886 A DK379886 A DK 379886A DK 379886 D0 DK379886 D0 DK 379886D0
- Authority
- DK
- Denmark
- Prior art keywords
- udpg
- tumps
- treating
- procedure
- preparation
- Prior art date
Links
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 abstract 3
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 abstract 3
- PQGCEDQWHSBAJP-TXICZTDVSA-N 5-O-phosphono-alpha-D-ribofuranosyl diphosphate Chemical compound O[C@H]1[C@@H](O)[C@@H](O[P@](O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O PQGCEDQWHSBAJP-TXICZTDVSA-N 0.000 abstract 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 101800000628 PDH precursor-related peptide Proteins 0.000 abstract 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 abstract 2
- VQPMXSMUUILNFZ-UHFFFAOYSA-N 3,7-dihydropurine-2,6-dithione Chemical compound S=C1NC(=S)NC2=C1NC=N2 VQPMXSMUUILNFZ-UHFFFAOYSA-N 0.000 abstract 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 abstract 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229960002949 fluorouracil Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 229960001428 mercaptopurine Drugs 0.000 abstract 1
- 229960000485 methotrexate Drugs 0.000 abstract 1
- 239000002213 purine nucleotide Substances 0.000 abstract 1
- 239000002719 pyrimidine nucleotide Substances 0.000 abstract 1
- 150000003230 pyrimidines Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Container Filling Or Packaging Operations (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68387384A | 1984-12-20 | 1984-12-20 | |
| PCT/US1985/002515 WO1986003678A1 (en) | 1984-12-20 | 1985-12-17 | Composition and method for treatment of tumors with udpg |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK379886A DK379886A (da) | 1986-08-08 |
| DK379886D0 true DK379886D0 (da) | 1986-08-08 |
Family
ID=24745804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK379886A DK379886D0 (da) | 1984-12-20 | 1986-08-08 | Praeparat og fremgangsmaade til behandling af svulster med udpg |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0205586B1 (da) |
| JP (2) | JPH0660103B2 (da) |
| AT (1) | ATE107509T1 (da) |
| AU (1) | AU586220B2 (da) |
| DE (1) | DE3587865T2 (da) |
| DK (1) | DK379886D0 (da) |
| NZ (1) | NZ214616A (da) |
| WO (1) | WO1986003678A1 (da) |
| ZA (1) | ZA859740B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA918336B (en) * | 1990-10-19 | 1992-06-24 | Boehringer Mannheim Italia | Udpg as a rescue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without bau |
| JPH07501810A (ja) * | 1991-12-16 | 1995-02-23 | ボーリンガー マンハイム イタリア ソシエタ ペルアツィオニ | 癌治療のレスキュー剤としてのｕｄｐｇの利用 |
| US6472378B2 (en) | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
| US6683060B2 (en) * | 2002-02-25 | 2004-01-27 | Advanced Gene Technology Corp. | Matrix metalloproteinase and tumor necrosis factor inhibitors |
| EP1948195A2 (en) * | 2005-11-17 | 2008-07-30 | Innate Pharma | Improved methods of using phosphoantigen for the treatment of cancer |
| US20100029674A1 (en) * | 2006-11-17 | 2010-02-04 | Innate Pharma, S.A. | Methods of Using Phosphoantigen for the Treatment of Cancer |
| CN112129938B (zh) * | 2019-06-25 | 2023-08-18 | 中国科学院分子细胞科学卓越创新中心 | UDP-Glc在肺癌转移评估中的应用 |
| CN111067868B (zh) * | 2019-12-20 | 2021-12-21 | 湖北盛齐安生物科技股份有限公司 | 一种载药囊泡 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1239700A (da) * | 1969-01-17 | 1971-07-21 | ||
| DE2016049C3 (de) * | 1970-04-03 | 1975-09-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur Herstellung von Nucleosiddiphosphaten bzw. ihren Estern |
| US3725201A (en) * | 1971-09-08 | 1973-04-03 | Marukin Shoyu Kk | Manufacture of uridine-5-diphosphoglucuronic acid |
-
1985
- 1985-12-17 AT AT86900528T patent/ATE107509T1/de not_active IP Right Cessation
- 1985-12-17 AU AU53125/86A patent/AU586220B2/en not_active Ceased
- 1985-12-17 DE DE3587865T patent/DE3587865T2/de not_active Expired - Fee Related
- 1985-12-17 JP JP61500288A patent/JPH0660103B2/ja not_active Expired - Lifetime
- 1985-12-17 EP EP86900528A patent/EP0205586B1/en not_active Expired - Lifetime
- 1985-12-17 WO PCT/US1985/002515 patent/WO1986003678A1/en not_active Ceased
- 1985-12-17 JP JP86500288A patent/JPS62501704A/ja active Pending
- 1985-12-18 NZ NZ214616A patent/NZ214616A/xx unknown
- 1985-12-20 ZA ZA859740A patent/ZA859740B/xx unknown
-
1986
- 1986-08-08 DK DK379886A patent/DK379886D0/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3587865T2 (de) | 1994-09-29 |
| WO1986003678A1 (en) | 1986-07-03 |
| EP0205586A4 (en) | 1990-01-08 |
| AU586220B2 (en) | 1989-07-06 |
| NZ214616A (en) | 1989-04-26 |
| JPS61501010A (ja) | 1986-05-22 |
| DE3587865D1 (de) | 1994-07-28 |
| JPH0660103B2 (ja) | 1994-08-10 |
| ATE107509T1 (de) | 1994-07-15 |
| DK379886A (da) | 1986-08-08 |
| JPS62501704A (ja) | 1987-07-09 |
| AU5312586A (en) | 1986-07-22 |
| ZA859740B (en) | 1986-07-30 |
| EP0205586A1 (en) | 1986-12-30 |
| EP0205586B1 (en) | 1994-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE296309T1 (de) | Wasserlösliche adenosin kinase inhibitoren | |
| EP0957903A4 (en) | PHARMACEUTICAL PREPARATIONS AND PROCEDURE | |
| NO975585L (no) | C-4' modifiserte adenosin-kinase inhibitorer | |
| ES2149276T3 (es) | Imidazo(4,5-c)piridin-4-aminas. | |
| BR9911612A (pt) | Composições de pirrolo[2,3d]pirimidina e seus usos | |
| DE69928235D1 (de) | Cyclin-abhängige kinase inhibitoren | |
| MX9400434A (es) | Potenciamiento de temozolomida en celulas de tumores humanos. | |
| ATE124412T1 (de) | Antivirusderivate von (phosphonmethoxy)methoxy purin/pyrimidin. | |
| DK379886A (da) | Praeparat og fremgangsmaade til behandling af svulster med udpg | |
| HU213677B (en) | Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them | |
| FI955906A7 (fi) | O6-substituoituja guaniinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö kasvainsolujen hoidossa | |
| NO954880L (no) | Cytidin deaminase | |
| ATE282627T1 (de) | Pyrimidinnukleotid-vorläufer zur behandlung entzündlicher hepatitis | |
| NO892125L (no) | Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler. | |
| SE8900835L (sv) | Foerbaettringar i samband med organiska foereningar | |
| ATE102247T1 (de) | Gamma-glutamylcysteintransferase, verfahren zu deren herstellung und deren verwendung. | |
| NO894658D0 (no) | Antivirale forbindelser. | |
| GR1000386B (el) | Μεθοδος παρασκευης 6-σουλφεναμιδο, 6-σουλφιναμιδο και 6-σουλφοναμιδο πουρινων, πουρινικων νουκλεοσιδιων, πουρινικων νουκλεοτιδιων και συναφων ενωσεων για την καταπολεμηση ογκων. | |
| Sukhorukov | Optical properties and molecular structure of nucleic acids and their components. 1. Infrared spectra and molecular structure of cytidine and cytidylic acid in the solid phase at different pH values | |
| Wang | The biochemical basis for the therapeutic synergism resulting from the combined use of 6-mercaptopurine and 6-(methylmercapto) purine ribonucleoside in the treatment of experimental tumors | |
| FR2070051A1 (en) | 4-hydroxy-beta-d-ribofuranosyl-pyrazolo 3 4-d |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ARF | Application refused |